Home » Topics » Regulatory » Patents

Patents
RSS

Mitsubishi Tanabe Pharma discloses novel BK and maxi K+ channel openers

Dec. 30, 2009

GlaxoSmithKline describes nAChR modulators as antipsychotic agents

Dec. 30, 2009

Novel DNA-binding compounds presented by CSIR

Dec. 30, 2009

Kappa-opioid receptor antagonists claimed by Janssen for treatment of addiction

Dec. 29, 2009

Allergan claims prostanoid EP2 receptor activators for glaucoma therapy

Dec. 29, 2009

Gilead discovers novel NS5B inhibitors for the treatment HCV infections

Dec. 29, 2009

Merck & Co. developing novel BACE1 inhibitors for neurologic conditions

Dec. 29, 2009

Novel MAPKAP5 inhibitors in development at Galapagos for the treatment of RA

Dec. 29, 2009

GSK presents novel compounds for the treatment of anemia

Dec. 29, 2009

Janssen discovers novel antibacterial agents

Dec. 29, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...